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Abstract
Design and characterization of artificial transcriptional terminators. Ten new ter-
minators were designed based on previous research of terminator structure and ter-
miantion efficiency. The terminators were built by PCR extension, ligated into a
BioBrick plasmid backbone, and transformed into TOP10 cells. Characterization de-
vices were built to test the terminators. Input and output of the terminator were
measured by expression of RFP and GFP. Charaterization devices were then placed
into the E. coli strain CW2553/pJAT18, which hijacks the arabinose transport system
to provide controlled input to the terminator. Of the ten terminators designed and
tested, BBa_B1002, BBaB1004, BBaB1006 and BBaB1010 proved to be strong ter-
minators with termination efficiencies above 90%. These terminators may be obtained
from the Registry of Standarized Parts at parts.mit.edu.
Thesis Supervisor: Thomas F. Knight Jr.
Title: Senior Research Scientist
3
4
Contents
1 Introduction
2 Background
2.1 Advances in Synthetic Biology . . . . . . . . . . . . . . . . . . . . . .
2.1.1 The abstraction barrier and its use . . . . . . . . . . . . . . .
2.1.2 The advance of BioBricks . . . . . . . . . . . . . . . . . . . .
2.1.3 Evolution of the genetic inverter . . . . . . . . . . . . . . . . .
2.2 Rho-independent Transcriptional Terminators . . . . . . . . . . . . .
2.2.1 Finding rho-independent terminators in prokaryote genomes .
2.2.2 Effects of structure on termination efficiency . . . . . . . . . .
2.2.3 Predicted termination efficiency given structure . . . . . . . .
19
21
21
21
22
24
25
26
27
27
3 Design and Construction of Artificial Transcriptional Terminators 31
3.1 D esign . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
3.1.1 H airpin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
3.1.2 Length of tail . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
3.1.3 Predicted efficiency . . . . . . . . . . . . . . . . . . . . . . . . 33
3.2 Construction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
3.2.1 Primer design . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
3.2.2 DNA purification . . . . . . . . . . . . . . . . . . . . . . . . . 36
3.2.3 Insertion into BioBrick backbone . . . . . . . . . . . . . . . . 37
3.2.4 Transformation into TOPlO competent cells . . . . . . . . . . 39
3.2.5 Plasmid recovery, verification, and storage . . . . . . . . . . . 39
5
3.2.6 Errors and Troubleshooting . . . . . . . . . . .4
4 Design and Construction of Characterization Devices 43
4.1 Design of terminator characterization devices . . . . . . . . . . . . . . 43
4.1.1 PoPS input generator . . . . . . . . . . . . . . . . . . . . . . . 45
4.1.2 Device under test . . . . . . . . . . . . . . . . . . . . . . . . . 46
4.1.3 Dual Fluorescent system . . . . . . . . . . . . . . . . . . . . . 46
4.1.4 C ontrols . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
4.2 Construction of Characterization Devices . . . . . . . . . . . . . . . . 48
4.2.1 Triple antibiotic assembly assembly . . . . . . . . . . . . . . . 52
4.2.2 Robotic assembly . . . . . . . . . . . . . . . . . . . . . . . . . 53
4.2.3 Verification . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
4.3 Transforming into an ideal strain . . . . . . . . . . . . . . . . . . . . 53
4.3.1 E. coli strain CW2553 . . . . . . . . . . . . . . . . . . . . . . 54
4.3.2 Making competent cells . . . . . . . . . . . . . . . . . . . . . . 54
4.3.3 Transformation of characterization devices into CW2553 . . . 55
5 Using Characterization Devices to Measure Termination Efficiency 57
5.1 M aterials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
5.1.1 M edia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
5.1.2 Characterization Devices . . . . . . . . . . . . . . . . . . . . . 59
5.1.3 Controls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
5.2 P rotocols . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
6 Results 61
6.1 C ontrols . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
6.1.1 Constitutive expression of RFP and GFP . . . . . . . . . . . . 61
6.1.2 Expression of RFP and GFP from empty characterization plas-
m ids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
6.2 Term inators . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
6.2.1 Results of characterization plasmid 1 . . . . . . . . . . . . . . 75
6
. . . . .. 41
6.2.2 Results of characterization plasmid 2 . . . . . . . . . . . . . . 76
6.3 Termination Efficiency . . . . . . . . . . . . . . . . . . . . . . . . . . 87
7 Discussion 95
7.1 Effects of mRNA stability . . . . . . . . . . . . . . . . . . . . . . . . 95
7.2 Accuracy of predicted termination efficiencies . . . . . . . . . . . . . 97
7.3 Future works . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
8 Conclusion 101
7
8
List of Figures
2-1 Abstraction barriers, shown in red, control the access of information
across abstraction levels. A sample exchange is shown in green. This
image was taken from http://parts.mit.edu. . . . . . . . . . . . . . . 22
2-2 Two BioBrick parts, blue and green, are combined to form one part.
This image was taken from http://parts.mit.edu. . . . . . . . . . . . 23
2-3 On left is a classic inverter, which uses Lac and cI as signals. A
high concentration of Lac inhibits the expression of the downstream
cI gene while a low concentration of Lac allows more transcription
and expression of cI. On the right is a PoPS based inverter, which
takes PoPS as both inputs and outputs. When the input is high, cI is
produced and acts to the keep the output PoPS low. This image was
taken from http://parts.mit.edu. . . . . . . . . . . . . . . . . . . . . 25
2-4 This image, taken from the d'Aubenton-Carafa paper, illustrates the
correlation between the calulated d score and the measured efficiency
of a terminator. Termination efficiency increases linearly as the d score
increases, and plateaus after the d score is higher that 40. . . . . . . . 29
4-1 Characterization plasmid version 1: controlled by ParaBAD, with inputs
measured by GFP expression and outputs measured by RFP expression. 43
4-2 Characterization plasmid version 2: controlled by ParaBAD, with inputs
measured by RFP expression and outputs measured by GFP expression. 44
4-3 Characterzation plasmid version 1 constructed using composite Bio-
Brick parts aviable in the Standard Registry. . . . . . . . . . . . . . . 44
9
4-4 Characterzation plasmid version 2 constructed using composite Bio-
Brick parts aviable in the Standard Registry. . . . . . . . . . . . . . . 45
4-5 113514: calibrates GFP input to RPF output . . . . . . . . . . . . . . 46
4-6 113515: calibrates RFP input to GFP output. . . . . . . . . . . . . . 47
4-7 113521: measures maximum RFP expression . . . . . . . . . . . . . . 48
4-8 113522: measures maximum GFP expression. . . . . . . . . . . . . . . 48
4-9 Triple antibiotic assembly is the method by which two BioBrick parts
are combined into a new part with a differnt antibiotic marker which
can then be used in futher constuctions. The image was taken from
http://openwetware.mit.edu . . . . . . . . . . . . . . . . . . . . . . . 52
6-1 This figure shows the measured GFP and RFP of controls 113521 and
113522 as compared to the negative control CW2553/pJAT18. Controls
113521 and 113522 respectively express RFP and GFP constitutively.
As expected, 113521 has negligible GFP expression and 113522 has
negligible RFP expression. The sample 113521 contained a population
of cells that produced neither GFP nor RFP, and those cells were
ignored when calculating the mean RFP expression. The mean RFP
of 113521 was 83.92, compared to the negative control of 2.17. The
mean GFP of 113522 was 15.12, compared to a negative control of
2.86. It is not know why constitutive GFP expression was much lower
than constitutive RFP expression. . . . . . . . . . . . . . . . . . . . . 62
10
6-2 This figure shows the measured GFP and RFP of controls 113514 and
113515 as compared to the negative control CW2553/pJAT18. Ide-
ally, 113514 and 113515 should have the same levels of GFP and RFP.
The majority of cells with the plasmid 113514 produced no significant
amounts of GFP or RFP. Of the cells producing significant fluorescence,
the mean GFP expression was 20.73, and the mean RFP expression was
17.2. As the majority of cells produced neither GFP nor RFP, 113514
cannot be used to accurately calibrate the ratio of input to output of
a terminator under test in version 1 of the characterization plasmid.
Due the possible presence of an RNAse cut site in the RFP coding
region, the control 113515 produced negligible RFP. The mean GFP
expression for 113515 was 210.3. . . . . . . . . .
6-3 Measurements of characterization device B3101
6-4 Measurements of characterization device B3102
6-5 Measurements of characterization device B3103
6-6 Measurements of characterization device B3104
6-7 Measurements of characterization device B3105
6-8 Measurements of characterization device B3106
6-9 Measurements of characterization device B3107
6-10 Measurements of characterization device B3108
6-11 Measurements of characterization device B3109
6-12 Measurements of characterization device B3110
6-13 Measurements of characterization device B3201
6-14 Measurements of characterization device B3202
6-15 Measurements of characterization device B3203
6-16 Measurements of characterization device B3204
6-17 Measurements of characterization device B3205
6-18 Measurements of characterization device B3206
6-19 Measurements of characterization device B3207
6-20 Measurements of characterization device B3208
11
. . . . . . . . . . . . 6 3
. . . . . . . . . . . . 6 5
. . . . . . . . . . . . 6 6
. . . . . . . . . . . . 6 7
. . . . . . . . . . . . 6 8
. . . . . . . . . . . . 6 9
. . . . . . . . . . . . 7 0
. . . . . . . . . . . . 7 1
. . . . . . . . . . . . 7 2
. . . . . . . . . . . . 7 3
. . . . . . . . . . . . 7 4
. . . . . . . . . . . . 7 7
. . . . . . . . . . . . 7 8
. . . . . . . . . . . . 7 9
. . . . . . . . . . . . 8 0
. . . . . . . . . . . . 8 1
. . . . . . . . . . . . 8 2
. . . . . . . . . . . . 8 3
. . . . . . . . . . . . 8 4
6-21 Measurements of characterization device B3209 . . . . . . . . . . . . 85
6-22 Measurements of characterization device B3210 . . . . . . . . . . . . 86
6-23 The figure shows a histogram of the termination efficiency of the ter-
minator B1001, calculated using the data from B3201. The average
termination efficiency is 0.81. . . . . . . . . . . . . . . . . . . . . . . 88
6-24 The figure shows a histogram of the termination efficiency of the ter-
minator B1002, calculated using the data from B3202. The average
termination efficiency is 0.99. . . . . . . . . . . . . . . . . . . . . . . 88
6-25 The figure shows a histogram of the termination efficiency of the ter-
minator B1003, calculated using the data from B3203. The average
termination efficiency is 0.83. . . . . . . . . . . . . . . . . . . . . . . 89
6-26 The figure shows a histogram of the termination efficiency of the ter-
minator B1004, calculated using the data from B3204. The average
termination efficiency is 0.94. . . . . . . . . . . . . . . . . . . . . . . 89
6-27 The figure shows a histogram of the termination efficiency of the ter-
minator B1005, calculated using the data from B3205. The average
termination efficiency is 0.86. . . . . . . . . . . . . . . . . . . . . . . 90
6-28 The figure shows a histogram of the termination efficiency of the ter-
minator B1006, calculated using the data from B3206. The average
termination efficiency is 0.98. . . . . . . . . . . . . . . . . . . . . . . 90
6-29 The figure shows a histogram of the termination efficiency of the ter-
minator B1007, calculated using the data from B3207. The average
termination efficiency is 0.83. . . . . . . . . . . . . . . . . . . . . . . 91
6-30 The figure shows a histogram of the termination efficiency of the ter-
minator BlO, calculated using the data from B3208. The average ter-
m ination efficiency is 0.95. . . . . . . . . . . . . . . . . . . . . . . . . 91
6-31 The figure shows a histogram of the termination efficiency of the ter-
minator B1009, calculated using the data from B3209. The average
termination efficiency is 0.94. . . . . . . . . . . . . . . . . . . . . . . 92
12
6-32 The figure shows a histogram of the termination efficiency of the ter-
minator B1010, calculated using the data from B3210. The average
termination efficiency is 0.96. . . . . . . . . . . . . . . . . . . . . . . 92
13
14
List of Tables
3.1 This table shows the structure and sequence of the designed terminators. 32
3.2 This table shows the calculated d scores and the predicted termination
efficiency for BioBrick terminators BIOOI-BI010. . . . . . . . . . . . . 34
3.3 This tables show the forward primers used to synthesize BioBrick ter-
minators B1001-BIOIO. . . . . . . . . . . . . . . . . . . . . . . . . . . 35
3.4 This tables shows the reverse primers used to synthesize BioBrick ter-
minators BlOOl-B1010. . . . . . . . . . . . . . . . . . . . . . . . . . . 35
4.1 A list of the BioBrick parts needed to construct the terminator char-
acterization plasmids and a short description of the function of those
parts. Data for these parts were found on the Standard Registry at
http://parts.m it.edu. . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
4.2 This table shows composite BioBrick parts availible from the registry
(http://parts.mit.edu). These composite parts were used in the con-
struction of the terminator characterization devices. . . . . . . . . . . 45
4.3 This table shows the function and component parts of the control plas-
mids. All controls are availible from parts.mit.edu . . . . . . . . . . . 47
4.4 This table shows the parts used to constuct the terminator character-
ization devices. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
4.5 This table shows the first construction step and the intermediate parts
created in making the terminator characterzation devices. . . . . . . . 50
15
4.6 This table shows the second construction used to create the termi-
nator characterization devices. The intermediate part from the first
construction is used as the right part in this construction . . . . . . . 51
6.1 This table shows the average GFP and RFP expression of the negative
control, 113514, 113515, 113521 and 113522. 113521 and 113522 con-
stitutively express RFP and GFP respectively. 113514 and 113515 are
used to calibrate input and output measurements of the characteriza-
tion devices. In cases of 113514 and 113521, which have two distinct
populations of cells, the cells which do not express sufficient fluores-
cence are discounted from the mean. . . . . . . . . . . . . . . . . . . 62
6.2 This table shows the mean GFP and RFP expression of characteriza-
tion plasmids B3101 through B3110. The mean GFP and RFP expres-
sion of the negative control CW2553/pJAT18 and 113514 are shown
for com parison. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
6.3 This table shows the mean GFP and mean RFP expression of charac-
terization plasmids B3201 through B3210. The mean GFP and RFP
expression of the negative control CW2553/pJAT18 and 113515 are
shown also for comparison. . . . . . . . . . . . . . . . . . . . . . . . . 76
6.4 This table shows the termination efficiencies of the new BioBrick ter-
minators B1001 through B1010. The strongest terminators are B1002
and B1006. The weakest terminator is B1001. . . . . . . . . . . . . . 87
16
7.1 This table shows the termination efficiencies of the new BioBrick termi-
nators BlOOl through BlOlO as well as the mRNA stabilization ability.
mRNA stabilization is based on much GFP was produced a terminator
was tested with version 1 of the characterization plasmid as compared
to control 113514. Strong terminators should also be able to stabilize
mRNA better than weak terminators. B1008 and B1009 have high %
TE, but are unable to stabilize mRNA. As the data from the two dif-
ferent characterization plasmids conflict for these two terminators, no
conclusions can be made about them. The best terminators are B1002,
B1004, B1006 and BlOlO. . . . . . . . . . . . . . . . . . . . . . . . . 96
7.2 This table shows sequences, predicted % TE, measured % TE, and the
error in the prediction. The strongest terminators are B1002, B1006,
B1010, and B1004. The formula used to predict termination efficiency
was most accurate when the terminator had approximately 6 thymine
residues in the tail. The most accurately predicted terminators were
B1002, B1003, B1006 and B1007.. . . . . . . . . . . . . . . . . . . . . 97
17
18
Chapter 1
Introduction
Synthetic biology creates biological systems using engineering design principles. The
goal of synthetic biology is to create and maintain a library of standardized and
fully characterized biological parts for the construction of artificial biological systems.
Currently, a library of biological parts used in synthetic biology can be found at
http://parts.mit.edu. The goal of this project was to design and characterize artificial
transcriptional terminators to further the advances of synthetic biology.
The registry possesses a collection of transcriptional terminators, but only have
detailed information regarding the performance of a few. Of the forty plus terminators
available before this project commenced, only five terminators in the collection were
both available for use, and were classified as working. The most efficient and thus
most commonly used terminator is B0015, which would appear a multitude of times
in a large biological device. The presence of repeats of DNA segments has been
known to cause unintended translocation of genetic elements, and may disrupt the
carefully designed genetic machines. It would be most beneficial to design a group
of terminators with high termination efficiency to lessen the likelihood of multiple
repeats.
A collection of transcriptional terminators with variable termination efficiency may
be used to control inputs to other genetic systems for purposes of characterizing other
genetic parts. Currently, controlled inputs may be generated by hijacking transport
systems already present, such as arabinose. Using transcriptional terminators to
19
control input instead of inherent metabolic systems allows separation of cell processes
from the introduced genetic system under test.
Ten artificial transcriptional terminators were designed and characterized. The
terminators were designed to achieve a range of termination efficiencies, and con-
formed to BioBrick standards for easy assembly with other genetic parts. The ter-
minators were built by PCR extension, ligated into BioBrick backbones, and trans-
formed into competent cells. Characterization devices testing the performance of the
terminators utilized fluorescent proteins to measure input and output and altered
the arabinose transport system to control inputs. The fluorescence produced by the
characterization devices were then measured using flow cytometry to calculate the
termination efficiency of the terminators.
20
Chapter 2
Background
2.1 Advances in Synthetic Biology
To simplify the task of engineering biological systems, the construction framework
BioBricks and its associated abstraction hierarchy were developed. The abstraction
hierarchy allows engineers working on one abstraction level to obscure everything in
the abstraction levels below it. The BioBrick construction framework allows simple,
easily repeatable assembly methods for creation of genetic machines [1].
2.1.1 The abstraction barrier and its use
The abstraction hierarchy defines abstraction levels and the interactions allowed be-
tween those levels [1]. The abstraction hierarchy and an ideal exchange of information
between levels is shown in Figure 2-1. Complexity at each level is reduced because
information not relevant to that level is obscured. For example, an engineer designing
genetic devices would need to know how the devices are used in systems, and what
parts are needed to construct the device, but would not need to know about DNA
synthesis.
21
I Systems tan I have
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tme thi DNA
TAATACGACCACTATAGGGAGA DNA 'Heres your DNA
Figure 2-1: Abstraction barriers, shown in red,
across abstraction levels. A sample exchange is
taken from http://parts.mit.edu.
control the access of information
shown in green. This image was
2.1.2 The advance of BioBricks
The goal of BioBricks is to standardize the form of genetic components to allow
idempotent reactions where the key structural elements of a component are unchanged
by the reactions. The outputs of such reactions can be used as the starting point in
subsequent reactions. BioBricks provide a standard method of assembling genetic
components using specified prefixes and suffixes.
BioBrick prefixes and suffixes
Each BioBrick part contains the component of interest flanked upstream by EcoRI
and XbaI restriction sites and downstream by Spel and PstI restriction sites [21. The
component should not contain any of the restriction sites. When creating a new
BioBrick part, PCR primers containing the BioBrick prefix and suffix are used to
turn the component in question into a BioBrick. The resulting PCR product can
then be cut with EcoRI and PstI, and ligated into the plasmid of choice. The primers
22
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Blue Part Gween Part
E X S P E X S P
Cut with Cut with
EcoRI and Spel EcoRI and XbaI
EX S
Mix and Ligate
(Blue-Green Part)
EX M S P
Figure 2-2: Two BioBrick parts, blue and green, are combined to form one part. This
image was taken from http://parts.mit.edu.
contain extra bases beyond the restriction sites to allowed restriction enzymes to bind
to the EcoRI and PstI sites.
BioBrick Prefix:
GAATTCGCGGCCGCTTCTAG for parts that start with AGT...
GAATTCGCGGCCGCTTCTAGAG for all other parts
BioBrick Suffix Primer:
TACTAGTAGCGGCCGCTGCAG for all parts
Assembly Methods
To combine two BioBrick parts A and B, part A is cut with EcoRI and Spel while
part B is cut with EcoRI and XbaI. The insert cut from part A and the insert from
part B are ligated together to a new backbone. The Spel and XbaI cut sites have
comparable overhangs, and can be ligated together to create a mixed site that is not
recognized by either restriction enzyme and cannot be cut. The resulting vector will
still be flanked by the appropriate restriction sites, but will contain the parts A and
23
B. This construction process is shown in Figure 2-2.
There are two ways to create a construct containing N BioBrick parts. The
first involves first joining two parts and then adding the subsequent parts in order.
This process will take a total N - 1 constructions, and weeks of time that might
not be able to be spared. The second method involves parallel assembly, shown in
Figure x. By performing multiple pairwise constructions in parallel, the number of
constructions can be reduced to log2 (N) from N. If error occurs in one construction
in parallel assembly, the failed part is ignored, and further construction continues
with successful constructs. However, such errors in the standard assembly would
require an additional stage to compensate for the failure. For these reasons, it is
more convenient to use parallel assembly when making large constructs.
2.1.3 Evolution of the genetic inverter
The common signal used by BioBrick for gene expression is PoPS (polymerase per
second) instead of a relying on a chemical signal. The PoPS level is set by the
number of RNA polymerase molecules that move across a particular section of DNA
[1]. Having a common signal means that any PoPS based device may be connected
to any other PoPS device. An example of a PoPS based device is a genetic inverter,
which takes a high input and returns a low output.
A PoPS based inverter fixes the main problem of a classic inverter: using proteins
as signals. A classic genetic inverter receives as input the concentration of protein A,
and through gene regulation, sends as output the concentration of the repressor B.
The problem with a classic inverter is that any device upstream of it must output a
concentration of protein A, and any device downstream from it must take as input
repressor B. Therefore, inversion of signal using a classic inverter requires two proteins.
A PoPS based inverter both takes PoPS as input and outputs PoPS and requires only
one protein, the repressor, for an inverter. Unlike the classic inverter, the specific
molecular interactions in a PoPS inverter are internal and can be hidden to reduce
complexity [1]. A comparison of a classic inverter and a PoPS based inverter is shown
in Figure 2-3.
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Figure 2-3: On left is a classic inverter, which uses LacI and cI as signals. A high
concentration of Lac inhibits the expression of the downstream cI gene while a low
concentration of LacI allows more transcription and expression of cI. On the right
is a PoPS based inverter, which takes PoPS as both inputs and outputs. When the
input is high, cI is produced and acts to the keep the output PoPS low. This image
was taken from http://parts.mit.edu.
2.2 Rho-independent Transcriptional Terminators
Transcriptional termination in prokaryotes is a complex process that involves RNA
polymerase and possible other protein factors. Terminators that can function in
vitro with only the DNA substrate and RNA polymerase are called intrinsic or rho-
independent terminators. This section will discuss the structure of rho-independent
terminators, the effects of structure on termination efficiency, and early attempts to
characterize BioBrick terminators. Unlike rho-dependent terminators, the charac-
teristics of rho-independent terminators are well understood, making it possible to
design new rho-independent terminators.
The majority of transcriptional terminators studied in the d'Aubenton Carafa [3]
paper have a G+C rich stem of 7(+/-1)bp and a loop of 4(+/-1) nucleotides followed
by a poly(T) tail. The most common loop size found was 4nt, with 55% of the
terminators studied having a loop of that size. Of the tetra-nucleotide loops found,
the most commonly repeated sequences were TTCG and GAAA, both of which are
known to increase RNA hairpin stability.
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2.2.1 Finding rho-independent terminators in prokaryote genomes
To identify rho-independent terminators in prokaryote genomes, one must find the
sequences that have high likelihood for hairpin formation that also have a T-tail of an
appropriate length. Calculations of hairpin predictions differ depending on the study,
but usually involve minimizing free energy of the stem loop structure. To calculate the
likelihood that a T-tail is present, several recent papers [4, 5] use a modified version
of the algorithm presented in the d'Aubenton Carafa paper. The algorithm favors
thymine residues closer to the stem loop, and penalizes presence of other nucleotides
in a 15 nt sequence. The original algorithm is as follows.
The parameter nT evaluates the importance of T residues going from 5' to 3'. To
calculate nT, a number x, is calculated for the nucleotide at position n as follows:
0.9 * Xn_1 if the nth nucleotide is a T
Xn -
0.6 * xn_- if the nth nucleotide is not a T
The value of xO, the first T residue is set to be 0.9.
To calculate nT:
n = EXn for all T residues in 15 residue segment
In the original paper, the authors considered a tail score of 2.895 to be the mini-
mum score for a real terminator.
The modified algorithm used by Ermolaeva in 2000 and Kingsford in 2007 calcu-
lates the tail score as follows to have a low score represent a T-rich tail.
15
n= - S x
n=1
where
0.9 * Xn- 1  if the nth nucleotide is a T
Xn-
0.6 * Xn- 1  if the nth nucleotide is not a T
for n = . .. 15 and xo = 1.
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2.2.2 Effects of structure on termination efficiency
The termination efficiency of a terminators depends on its particular stem loop struc-
ture and the length of the poly(T) tail. In general, disruption of stem loop structure
lowers termination efficiency more than disruption of the poly(T) tail [6]. Destroying
the G+C dyad symmetry of the stem by either creating mismatches or by replacing
all G+C pairs with A+T pairs will greatly reduce the termination efficiency by up
to 90% [6]. Decreasing the free energy of the stem does not guarantee an increase in
termination efficiency [7, 8]. In some cases [7], replacing the loop of a terminator with
the sequence TTCG will stabilize the RNA hairpin, and slightly increase termination
efficiency.
The effects of disruption of the poly(T) tail is much more straight forward. The
termination efficiency increases linearly with the number of thymine residues present
up to around 7 residues. The addition of more residues does not further increase the
termination efficiency [9].
2.2.3 Predicted termination efficiency given structure
The structure of a terminator can be used to predict its efficiency using a formula
developed by d'Aubenton-Carafa. The formula was used to calculate a factor d, which
described the likelihood of a given sequence being a terminator, but could also be used
to predict termination efficiency.
d = nT * 18.16 + Y * 96.59 - 116.87
where nT is the tail score calculated as follows:
nT= S Ex for all T residues in 15 residue segment
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0.9
Xn 0.9 * X"-1
0.6 * x,_1
if n = 1
if the nth nucleotide is a T
if the nth nucleotide is not a T
and
Y =-AG
LH
where -AG is the free energy of hairpin formation and LH is the number of
nucleotides in the entire stem loop
In general, the higher the d score, the higher the termination efficiency. Shown
in Figure 2-4 is a figure taken from the d'Aubenton-Carafa paper that relates the d
score of a variety of terminators to their measured termination efficiencies.
28
100
00
E a
so - a a
.60-
*& /40
-20 0 20 40 60
Score d
Figure 7. Diagram showing the correlation between the
score d of some rho-independent terminators and their
efficiency in vitro. We name the terminators by the name
of the preceding gene or operon: (]) rrnB TI (Schmidt &
Chamberlin, 1987), bacteriophage T7 Te (Chamberlin et
at, 1979); (A) ampL attenuator and ampL35A mutant
(Jaurin et at, 1981); (0) in40 (Sacerdot et at, 1982;
ref. (13) in Table 2A), pheS attenuator (Fayat et at, 1983;
ref. (65) in Table 2A), his attenuator (Frunzio et at, 1981;
ref. (68) in Table 2A), trpt and trpCJ01 and 1rpC302
mutants (Christie et al., 1981), bacteriophage T3 Te (Neff
& Chamberlin, 1980); (A) tonB (both directions) (Postle &
Good, 1985; ref. (122) in Table 2A), rpLT (Fayat et at,
1983; ref. (65) in Table 2A); (0) trp attenuator, rp a1419
and frp a135 mutants (Christie et at, 1981), trpL77,
trpL78, trpL80, frpLl53 mutants (Stauffer et al, 1978);
(U) thr attenuator and T2, T3, T4, 75, T6, T mutants in
the poly(U) stretch (Lynn et at, 1988); ([E) thr attenuator
stem mutants t135U, L138U, L139A, L140A, L151A,
L151U, L153A, L153U, L153+0, L153-G, L156U
(Lynn et al, 1988); (x) rnpB (Sakamoto it at, 1983); (+)
intracistronic signals in eca (this work).
Figure 2-4: This image, taken from the d'Aubenton-Carafa paper, illustrates the
correlation between the calulated d score and the measured efficiency of a terminator.
Termination efficiency increases linearly as the d score increases, and plateaus after
the d score is higher that 40.
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Chapter 3
Design and Construction of
Artificial Transcriptional
Terminators
This chapter describes the design and construction of ten artificial transcriptional ter-
minations with a theoretical range of termination efficiencies from 10% to 90%. These
ten terminators are in the registry of standard parts as BBaB1001 to BBa_B1010.
3.1 Design
The ten terminators are split into two series based on their stem-loop sequence.
Series A contains terminators BBaB1001 through BBaB1005, while series B con-
tains BBaB1006 through BBa_1010. Each series has five terminators with varying
thymines in their poly(T) tails. As previous studies show it is easier to predict ter-
mination efficiency by truncating the poly(T) tail, I have chosen that method to vary
the termination efficiency of these terminators. The stem loop and tail sequences of
these terminators are shown in Table 3.1.
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Table 3.1: This table shows the structure and sequence of the designed terminators.
Part Name Stem-Loop Sequnce Loop Tail
BBaB1001 CCCCGCTTCGGCGGGG TTCG TTTTTTTTT
BBaB1002 CCCCGCTTCGGCGGGG TTCG TTTTTT
BBaB1003 CCCCGCTTCGGCGGGG TTCG TTTTT
BBaB1004 CCCCGCTTCGGCGGGG TTCG TTTT
BBa_1B1005 CCCCGCTTCGGCGGGG TTCG TTT
BBaB1006 CCCCGCCCCTGACAGGGCGGGG CTGACA TTTTTTTTT
BBaB1007 CCCCGCCCCTGACAGGGCGGGG CTGACA TTTTTT
BBa-B1008 CCCCGCCCCTGACAGGGCGGGG CTGACA TTTTT
BBa-B1009 CCCCGCCCCTGACAGGGCGGGG CTGACA TTTT
BBaB1O1O CCCCGCCCCTGACAGGGCGGGG CTGACA TTT
3.1.1 Hairpin
All terminators in Series A have a stem of 6nt and a loop of 4nt. The stem seqence,
GGGGCG, is the consensus sequence found for terminators with 4nt loops in the
d'Aubenton-Carafa paper. The loop, TTCG, is one of two loop sequences known to
stabilize the mRNA hairpin. Series B terminators are a variation of the thr termina-
tor. All A-T pairs in the stem of the thr terminator were replaced by G-C pairs, and
the first G-C pair was changed into a C-G pair. Removal of the A-T pairs should
increase the stability of the stem-loop structure. Series B terminators have a stem of
8bp, and a loop of 6nt.
3.1.2 Length of tail
The lengths of the poly(T) tail in each series goes from a minimum of 3nt to a
maximum of 9nt. In theory, additional T residues beyond 6nt would not further
increase termination efficiency. Additionally, termination efficiency increases linearly
as the poly(T) tail increases from 3nt to 6nt. Only one terminator in each series
has a poly(T) tail greater than 6nt at 9nt. The other terminators have poly(T) tails
ranging from 3nt to 6nt.
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3.1.3 Predicted efficiency
The paper by d'Aubenton-Carafa suggests that the same algorithm used to predict
the presence of a terminator can also be used to estimate termination efficiency of a
given terminator. The termination efficiency can be predicted as a function of the
total length of the terminator, the free energy of the stem loop structure, and number
of thymine residues in the stretch of 15 nt after the stem loop:
d = nr * 18.16 + Y * 96.59 - 116.87
where nT is the tail score calculated as follows:
nr = EX for all T residues in 15 residue segment
0.9
Xn 0.9 * Xn_1
0.6 * n_1
if n = 1
if the nth nucleotide is a T
if the nth nucleotide is not a T
and
Y-= AG
LH
where -AG is the free energy
nucleotides in the entire stem loop
of hairpin formation and LH is the number of
structure.
Python scripts were written to calculate both d and nT. The energy of hairpin
formation for a given sequence was calculated using UNAFold [10]. A summary of
the d scores and predicted efficiencies of terminators BBa-B1001 through BBaB1010
is shown in Table 3.2.
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Table 3.2: This table shows the calculated d scores and
efficiency for BioBrick terminators B1001-B1010.
the predicted termination
Part Name -AG Length Tail Score d score Predicted Efficiency
BBa-B1001 -12.6 16 5.68 62.33 95%
BBaB1002 -12.6 16 4.35 38.25 90%
BBaB1003 -12.6 16 3.78 27.78 80%
BBaB1004 -12.6 16 3.16 16.05 55%
BBaB1005 -12.6 16 2.48 4.22 25%
BBaB1006 -16.2 22 5.68 57.39 95%
BBaB1007 -16.2 22 4.35 33.32 80%
BBaB1008 -16.2 22 3.78 22.84 70%
BBaB1009 -16.2 22 3.16 11.56 40%
BBa-B1010 -16.2 22 2.48 0.72 10%
3.2 Construction
Five rounds of construction were needed to create these terminators. This count does
not include rounds of construction that yielded no successful construct. The first
round yielded BBaB1004. BBa_1007, BBa-1005, and BBa1001 were completed in
rounds 2, 3, and 4 respectively. All other terminators were completed in round 5.
The terminators were made by overlapping primers and extending them by PCR.
The PCR products were then purified, and cut with EcoRI and PstI. The BioBrick
plasmid backbone was also made by PCR and cut with the same restriction enzymes.
The insert and backbone were the ligated together and transformed into TOP10 cells.
3.2.1 Primer design
The process of making BioBrick parts from the designed sequences begins with cre-
ating PCR primers to turn the sequence from text on paper to a stretch of DNA .
The forward and reverse primers overlap from 2nt before the loop to 2nt after the
loop. This creates a 8bp overlap for series A terminators and a 10bp overlap for series
B terminators. Ideally, the forward and reverse primers would only overlap at the
loop, but a 4bp or 6bp overlap is not sufficient for binding. Extending the overlap 2nt
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Table 3.3: This tables show the forward primers used to synthesize BioBrick termi-
nators B1001-B1010.
Part Name Forward Primer
BBaB1001 GTTTCTTCGAATTCGCGGCCGCTTCTAGAGAAAAAAAAACCCCGCTTCGGC
BBaB1002 GTTTCTTCGAATTCGCGGCCGCTTCTAGAGCGCAAAAAACCCCGCTTCGGC
BBa-B1003 GTTTCTTCGAATTCGCGGCCGCTTCTAGAGCGCCAAAAACCCCGCTTCGGC
BBa_B1004 GTTTCTTCGAATTCGCGGCCGCTTCTAGAGGCCGAAAACCCCGCTTCGGC
BBaB1005 GTTTCTTCGAATTCGCGGCCGCTTCTAGAGCGCCGCAAACCCCGCTTCGGC
BBaB1006 GTTTCTTCGAATTCGCGGCCGCTTCTAGAGAAAAAAAAACCCCGCCCCTGACAGG
BBa-B1007 GTTTCTTCGAATTCGCGGCCGCTTCTAGAGCGCAAAAAACCCCGCCCCTGACAGG
BBa_B1008 GTTTCTTCGAATTCGCGGCCGCTTCTAGAGCGCCAAAAACCCCGCCCCTGACAGG
BBaB1009 GTTTCTTCGAATTCGCGGCCGCTTCTAGAGCGCCGAAAACCCCGCCCCTGACAGG
BBaB1O1O GTTTCTTCGAATTCGCGGCCGCTTCTAGAGCGCCGCAAACCCCGCCCCTGACAGG
Table 3.4: This tables shows the reverse primers used to synthesize BioBrick termi-
nators B1001-BlOlO.
Part Name Reverse Primer
BBaB1001 GTTTCTTCCTGCAGCGGCCGCTACTAGTAAAAAAAAACCCCGCCGAAGC
BBaB1002 GTTTCTTCCTGCAGCGGCCGCTACTAGTAGCGAAAAAACCCCGCCGAAGC
BBa_B1003 GTTTCTTCCTGCAGCGGCCGCTACTAGTAGCGGAAAAACCCCGCCGAAGC
BBa-B1004 GTTTCTTCCTGCAGCGGCCGCTACTAGTACGGCAAAACCCCGCCGAAGC
BBa-B1005 GTTTCTTCCTGCAGCGGCCGCTACTAGTAGCGGCGAAACCCCGCCGAAGC
BBaB1006 GTTTCTTCCTGCAGCGGCCGCTACTAGTAAAAAAAAACCCCGCCCTGTCAGGG
BBa_BI007 GTTTCTTCCTGCAGCGGCCGCTACTAGTAGCGAAAAAACCCCGCCCTGTCAGGG
BBaB1008 GTTTCTTCCTGCAGCGGCCGCTACTAGTAGCGGAAAAACCCCGCCCTGTCAGGG
BBa_B1009 GTTTCTTCCTGCAGCGGCCGCTACTAGTAGCGGCAAAACCCCGCCCTGTCAGGG
BBa_B1010 GTTTCTTCCTGCAGCGGCCGCTACTAGTAGCGGCGAAACCCCGCCCTGTCAGGG
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each way beyond the loop should provide adequate strength for binding, but should
not cause the primers to form a hairpin with themselves. Both forward and reverse
primers have extra bases beyond the EcoRI and PstJ cut sites to ensure the restric-
tion enzyme can bind to the site effectively. The forward and reverse primers used to
construct terminators BBaB1001 through BBa..B1O1O are shown in Tables 3.3 and
3.4.
3ul of each of the primers were added to 40ul of Fidelity PCR supermix. The
primers would overlap and form the template, so no additional template DNA was
required. The samples were placed in the thermocycler for 20 extension cycles. PCR
products were then run on Metaphor 3.5% agarose gels to check for length. It took
some experimentation to determine what percentage gel to use to separate the product
from primers because the DNA fragments were only twice the size of the primers, and
typical 1-1.5% agarose gels don't have the definition to separate 100bp products from
50bp primers.
3.2.2 DNA purification
The PCR product must be purified to remove all remaining primers and unused
nucleotides. Purification was complicated by the relatively short length of the PCR
product (9Obp). Two methods of PCR used were gel purification and a modified
version of the Qiagen PCR purification protocol.
Gel purification
The first attempts to purify the PCR were done with the Qiagen gel purification kit.
The PCR products were run on Metaphor 3.5% gels, and the appropriate bands were
cut and placed into 2ml tubes. The tubes were weighed, and QX1 buffer equal to
6 times the weight of the gel was added to each tube. Ten microliters of QIAEX II
beads were added, and the tubes were incubated for 10 minutes at 50 degrees C. The
tubes were vortexed every two minutes to keep the QIAEX II beads in suspension.
After incubation, the tubes were centrifuged for 30 seconds, and the supernatant
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removed. The remaining pellets were then washed with 500 ul of QXI buffer once,
and 500 ul of PE twice. The pellets were then left to air dry for 15 minutes until they
turned white. To elute the DNA from the QIAEX II beads, 50ul of Qiagen elution
buffer was added to each tube, and the pellets were resuspended. After 5 minutes of
incubation on the bench, the tubes were centrifuged, and the supernatant containing
the DNA stored at -20 C.
For reasons yet unknown, not all uses of the kit yielded any DNA but this mistake
was not noticed until the fourth round of construction. An alternative method was
found for purifying PCR products in the fourth round of terminator construction.
Alternate protocol for PCR purification
This protocol used Qiagen solutions PB, PE, and EB as well as Qiagen miniprep
columns. The sample and 5 times as much PB were applied to the miniprep column,
and the column was spun for 1 minute at 3000G. The flowthrough was then applied
to the column, and this procedure was repeated twice. After the third spin, the
flowthrough was discarded, and 750 ul of PE was added to the column. The column
was then spun for 1 minute at 3000G; the flow through was discarded, and the column
spun again for 3 minutes at 17900G to remove all residual PE, which might hamper
later reactions. After spinning, the column was transferred to a new tube, and 30 ul
of EB was added. The column was incubated on the bench at room temperature for
5 minutes, and then spun for one minute at 6800G. Another 30 ul of EB was added,
and the column was incubated for another 5 minutes. The column was spun for a
final time for 5 minutes at 6800G to recover the PCR products.
3.2.3 Insertion into BioBrick backbone
After the PCR product is purified, it must be ligated into an approved BioBrick
backbone to form a BioBrick part. BioBrick backbones carry one of kanamycin ,
chloramphenicol, or tetracycline resistance markers in addition to ampicillin resis-
tance. Backbones can be created by miniprepping cultures carrying the backbone
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plasmid or by building the backbone using a template and PCR primers. Both the
backbone and the insert are cut with appropriate restriction enzymes, and ligated
together.
Creation of backbone
I chose to use the backbone with the kanamycin resistance marker for the terminator
BioBrick. I used PCR to build the backbone as this method generally yielded higher
concentrations of backbone DNA than miniprepping cultures with the appropriate
plasmid. The backbone was then purified using the protocol described earlier.
Digestion and ligation
Both the backbone and the insert were cut with EcoRI and PstI. Each digest was
set up with 20 ul DNA, 1 ul of each of the enzymes, 5 ul of NEB buffer 2 at 10x
concentration, 0.5 ul of BSA at 100x concentration and 22.5 ul of distilled water.
These digests were then incubated at 37 degrees C for 2 hours for the enzymes to cut
the DNA, and then heated to 80 degrees C to heat kill the enzymes. Cut DNA should
be stored in TE buffer at -20 degrees C to reduce chances of cut ends degrading.
Once both inserts and backbones have been cut with the correct enzymes, they
should be ligated to form a BioBrick part. A rough ratio of 3:1 insert to backbone
should be present in the ligation reactions. Adding too much insert causes the inserts
to ligate to each other, forming final products with repeats of three to five inserts in
one backbone. It is also possible for the backbones to ligate to each other, but these
constructs never form viable colonies, and thus is not a problem. The formula to
calculate the amount of insert to add to a reaction is given by the following formula:
ng insert = 3 * fracng vector * kb insertkb vector
The ligation mixtures contained lul 10x T4 DNA ligase buffer, 1 ul plasmid back-
bone, the amount of insert needed as calculated by the formula above, 0.3 ul T4 DNA
ligase, and enough water to make a final volume of 10ul. The water is added first, and
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the ligase added last. The final mixture should have equimolar amounts of plasmid
backbone and insert DNA. The ligations are incubated at room temperature for 15
minutes, and then used immediately to transform competent cells.
3.2.4 Transformation into TOP10 competent cells
The finished ligation products are transformed into TOP10 competent cells, and the
cultures with the correct BioBrick part are store for future use. The competent cells
are thawed on ice, and 10 ul of cells are aliquoted for each transformation. The cells
are then diluted with 40ul CMB800 to increase transformation efficiency. 1 ul of the
appropriate ligation product is added to each aliquot, and the cells are kept on ice for
thirty minutes. The cells are then heat shocked for 50 seconds at 42 degrees C, and
put on ice again for two minutes. SOC media is added to the cultures, and the cells
are incubated at 37 degrees C to recover antibiotic resistance before being plated out
and grown overnight at 37 degrees C. Generally, one hour of incubation is enough to
recover resistance to kanamycin or ampicillin, but two hours is preferable when using
tetracycline or chloramphenicol as resistance markers.
At first, I added 1 ml of SOC to each culture, and plated out two plates per culture,
one with 200ul and the other with 20ul. I found that these plates rarely yielded enough
colonies, particularly the plates spread with 20ul. I switched to adding 250ul of SOC
to each culture, and plating out the entire culture. This approach tended to yield at
least one colony per transformation.
3.2.5 Plasmid recovery, verification, and storage
DNA was recovered from the transformants by minipreps, and was then verified for
the presence of the correct BioBrick part. If the part was correct, then the cells would
be prepared for storage.
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Minipreps to recover plasmid DNA
The following day, one colony was picked from each plate of transformants and grown
up for minipreps in LB broth. I used the Qiagen miniprep kit to perform these
minipreps. First, 1.7 ml of culture were spun down to obtain a pellet of cells. The
pellet was resuspended in 250 ul of P1 buffer, and vortexed for 30 seconds to lyse
the cells. 250 ul of P2 buffer was then added, and the tube was gently inverted 6
to 10 times. The tube was not vortexed at this time as it would result in shearing
of the genomic DNA. After the solution has turned an even shade of blue, 350 ul of
N3 buffer was added to stop the reaction. Once the solution turned colorless and
cloudy after inverting the tube 6-10 times, the tube was centrifuged at 17900G for 10
minutes.
The supernatant was then transferred to a miniprep spin column, and the column
spun for 1 minute. The flowthrough was discarded, and 500ul of PB buffer was
applied to the column. The column was spun again for 1 minute, and 750 ul of PE
was added. The column was then spun twice to remove all PE, which could hamper
future reactions. Afterwards, the column was transferred to a clean tube. 50 ul of
EB was applied, and the column was incubated on the bench at room temperature
for 5 minutes. The tube was then spun for 3 minutes at 6800G to recover the plasmid
DNA. The DNA obtained from these minipreps is then used to verify the existence
of the correct BioBrick part.
Verification of BioBrick part
The plasmid DNA recovered from the minipreps were first cut with one restriction
enzyme and run on a 1.5% agarose gel to check for its presence. The concentration of
the plasmid DNA was then measured with the NanoDrop spectrometer and recorded.
PCR primers VF2 and VR were then used to measure the length of the insert using
the plasmid DNA as the template. VF2 binds to the template before the BioBrick
prefix, and VR binds to the template after the BioBrick suffix. The resulting PCR
product was then run on an 1% agarose gel to measure its length. If the length was
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correct, the plasmid DNA was then sent out for sequencing at the MIT Sequencing
Center. Each sample contained 200ng plasmid DNA, 0.3 ul of either VF2 or VR, and
enough water to make a final volume of 12 ul.
Storage of cultures
If the culture contains the correct BioBrick part, it will be prepared to be stored
at -80 degrees C for future use. A solution of 85% cell culture and 15% glycerol is
vortexed for 30 seconds to mix it well, and then incubated on the bench at room
temperature for 30 minutes. The solution is then stored in the -80C freezer until it
is needed. From past experience, incubation for periods longer than 30 minutes does
not seem harm the cells. I use an 80% glycerol solution to make these frozen cultures
since it is easier to accurately pipette than 100% glycerol.
3.2.6 Errors and Troubleshooting
A number of problems occurred during the construction phase including but not
limited to: setting the thermocycler to the wrong temperatures for PCR extension
when creating the parts, not being able to recover DNA with the gel extraction
kit, and degraded cut ends on the backbone which caused the backbone to ligate
shut. Perhaps the most perplexing instance was that of transformants which grew on
antibiotic plates but lacked the plasmid and insert when miniprepped. In addition,
when streaked out from prepared glycerols, the transformants again grew on antibiotic
plates, but would not grow in liquid media. After trying in vain to recover plasmid
DNA from these transformants for two weeks, these transformants were scrapped,
and a new set of construction started.
A common problem faced with these constructions was the insertion of genomic
DNA into the plasmid during the transformations. This was noticed when the Bio-
Brick site was amplified with PCR and run on gels. For these terminators, the
approximate size should be around 350 bp. When genomic DNA was inserted instead
of the BioBrick part, the size of the insert ranged from 350bp to 750bp. If the length
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was around 300, it meant that nothing had been inserted, and the backbone was
ligated to itself.
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Chapter 4
Design and Construction of
Characterization Devices
The next goal after creating the terminators was to develop devices that would allow
characterization of the new BioBrick terminators. The characterization devices for
the artificial terminators use a GFP/RFP dual fluorescent system with the inputs to
the system controlled by the promoter. The characterization devices were constructed
using 3A assembly, described in 4.2.1, either performed by hand or by robot. The
finished constructs were then transformed into E. coli strain CW2553.
4.1 Design of terminator characterization devices
The input to the characterization devices is controlled by the ParaBAD system. The
terminator to be characterized is flanked by two fluorescent proteins, GFP and RFP,
RBS G FP T erminator RBS RFP T erminator
c t D 
under test
Figure 4-1: Characterization plasmid version 1: controlled by ParaBAD, with inputs
measured by GFP expression and outputs measured by RFP expression.
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P rLBADRBS RFP Terminator RBS G FP T erm inator
77Dunder test
Figure 4-2: Characterization plasmid version 2: controlled by ParaBAD, with inputs
measured by RFP expression and outputs measured by GFP expression.
Table 4.1: A list of the BioBrick parts needed to construct the terminator characteri-
zation plasmids and a short description of the function of those parts. Data for these
parts were found on the Standard Registry at http://parts.mit.edu.
Part Name Part Type Description
BBaI0500 promoter inducible ParaBAD
BBa-E0034 RBS strong RBS
BBa.EO040 reporter generates GFP
BBa_E1O1O reporter generates RFP
BBaB0015 terminator terminator with high TE
which are used to measure the termination efficiency of the terminator. The charac-
terization devices are made entirely from BioBrick parts found in the registry. Parts
used to construct these devices are shown in Table 4.1. Figure 4-1 shows the ver-
sion of the characterization device using GFP expression to measure input and RFP
expression to measure output. Figure 4-2 shows a characterization device using the
opposite measuring scheme.
Some of the parts used to construct the characterization devices are available in
composite parts. Using the composite parts instead of the individual parts speed up
BBa I-13 506 T erm inat or B BaI I13 507
under test7 D
Figure 4-3: Characterzation plasmid version 1 constructed using composite BioBrick
parts aviable in the Standard Registry.
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... . .. B B aI113 5 04 T erm inator B Ba I13516
under test
Figure 4-4: Characterzation plasmid version 2 constructed using composite BioBrick
parts aviable in the Standard Registry.
Table 4.2: This table shows composite BioBrick parts availible from the registry
(http://parts.mit.edu). These composite parts were used in the construction of the
terminator characterization devices.
Part Name Components
BBaI13506 10500, E0034, E0040
BBaI13507 E0034, E1010, B0015
BBaI13516 10500, E0034, E1010
BBaI13504 E0034, E0040, B0015
the construction process by reducing the number of assemblies needed. The composite
parts used to construct the characterization devices are described in Table 4.2. The
final constructs are shown in Figures 4-3 and 4-4.
4.1.1 PoPS input generator
The PoPS generator must be able to vary the input signal to produce a wide range
of outputs for device characterization. One possible way to produce a wide range
of PoPS inputs is to use an inducible promoter such as the arabinose promoter,
ParaBAD. However, inducing the araBAD operon at subsaturation concentrations
results a population of cells which exhibit linear behavior in response to chances in
inducer concentration but individual cells with either be fully induced or not induced.
Decoupling the arabinose transport gene araE from the ParaBAD promoter and putting
it under the control of an arabinose independent promoter will remove the all-or-none
effects and produce a population of cells that will exhibit linear behavior in ParaBAD
expression as a function of arabinose concentration at an individual level with all
cells in the population having a similar level of expression as shown in the paper by
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Pms RBS F RBS RFP T erminator
Figure 4-5: 113514: calibrates GFP input to RPF output
Khlebnikov et al [11].
4.1.2 Device under test
The new BioBrick terminators will be the devices under test for these measurement
devices. A list of terminators tested is shown earlier in Table 3.1.
4.1.3 Dual Fluorescent system
The DUT is flanked by two fluorescent proteins, GFP and RFP. The fluorescent
protein preceding the DUT measure inputs to the DUT while the fluorescent protein
following the DUT measures the output.
The termination efficiency will by measured by the ratio of the first fluorescent
protein produced to the second protein produced. If the terminator has a high termi-
nation efficiency, very little fo the second protein will be produced. If the terminator
has low termination efficiency, there should be no difference in the levels of the first
and second proteins. In the off chance that one of the terminators acts as a promoter,
more the second protein will be produced than the first protein.
Two sets of the characterization devices were constructed. The first set has GFP
flanking on the left of the DUT and RFP flanking on the right. The second set is
reversed with RFP on the left, and GFP on the right. This allows calibration of the
input and output measurements.
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Table 4.3: This table shows the function and component parts of the control plasmids.
All controls are availible from parts.mit.edu.
Part Name Description Componenets
BBaI13514 Calibration of GFP input to RFP output 10500, E0034, E0040,
E0034, E1010, B0015
BBaI13515 Calibration of RFP input to GFP output 10500, E0034, E1010,
E0034, E0040, B0015
BBaJI13521 Maximum RFP output R0040, E0034, E0040,
B0015
BBaI13522 Maximum GFP output R0040, E0034, E1010,
11_ 1 B0015
FarBAD R B 1 
RFP iBS GFP 
ountt.
Figure 4-6: I13515: calibrates RFP input to GFP output.
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PT et RB 7 RFP T erminatorD
Figure 4-7: 113521: measures maximum RFP expression
P Tet R BS G FP T erm inator
Figure 4-8: 113522: measures maximum GFP expression.
4.1.4 Controls
Controls were needed to calibrate the levels of GFP and RFP expression in the char-
acterization constructs. A list of controls used is shown in Table 4.3, and all controls
are available from the Standard Registry. The controls 113514 and 113515 have the
same components as the characterization devices, but lack a DUT. These are used to
calibrate the input and output between the two sets of characterization devices by
showing normal GFP and RFP expression without interference from the DUT, and
are shown in Figures 4-5 and 4-6.
Constructs 113521 and 113522 each have a fluorescent protein, RFP and GFP
respectively, under the control of a constitutive promoter, TetR. These controls test
the maximum levels of GFP and RFP expression and are shown in Figures 4-7 and
4-8.
4.2 Construction of Characterization Devices
The characterization devices were constructed using the triple antibiotic rolling as-
sembly method performed either by hand or by robot. Finished constructs were sent
out for sequencing to verify the existence of the correct construct. The complete list
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Table 4.4: This table shows the parts used to constuct the terminator characterization
devices.
Part Name Left Part DUT Right Part
BBaB3101 BBa-113506 BBaB1001 BBaI13507
BBaB3102 BBaI13506 BBaB1002 BBaAI13507
BBaB3103 BBa_113506 BBa-B1003 BBaI13507
BBa-B3104 BBa-I13506 BBaB1004 BBaI13507
BBa-B3105 BBaI13506 BBa-B1005 BBaI13507
BBaB3106 BBaI13506 BBa_B1006 BBaI13507
BBaB3107 BBaI13506 BBaB1007 BBaI13507
BBaB3108 BBa-I13506 BBaB1008 BBaI13507
BBa-B3109 BBa_113506 BBaB1009 BBa-I13507
BBa-B3110 BBa-I13506 BBaB101O BBaI13507
BBa-B3201 BBaI13516 BBaB1001 BBaI13504
BBaB3202 BBaI13516 BBa-B1002 BBaI13504
BBa-B3203 BBa_113516 BBa-B1003 BBaI13504
BBaB3204 BBaI13516 BBaB1004 BBaI13504
BBaB3205 BBaI13516 BBaB1005 BBaI13504
BBaB3206 BBaI13516 BBaB1006 BBaI13504
BBa-B3207 BBaI13516 BBa-B1007 BBa-I13504
BBaB3208 BBaJI13516 BBaB1008 BBaI13504
BBaB3209 BBaI13516 BBaB1009 BBaI13504
BBa-B3210 BBaJI13516 BBaB1O1O BBaI13504
of all constructions is shown in Table 4.4.
The characterization devices were made in two steps. The first set of constructions
and the resulting intermediate parts is shown in 4.5. Terminators were combined with
either BBa_13507 or BBa-I13504 to form the intermediate parts BBaB11XX and
BBaB12XX. The intermediate parts were then combined with either BBaI13506 or
BBaI13516, with the details of these constructions shown in Table 4.6.
The constructions shown in Table 4.5 were assembled using triple antibiotic as-
sembly performed by hand. Constructions shown in Table 4.6 were assembled by the
same methods using the robot. All constructions that failed in the first round were
subsequently assembled by hand.
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Table 4.5: This table shows the first construction step and the intermediate parts
created in making the terminator characterzation devices.
Part Name Left Part Right Part Description
BBaB1101 BBa-B1001 BBa-I13507 BlOOl + rfp
BBa-B1102 BBa-B1002 BBaI13507 B1002 + rfp
BBaB1103 BBaB1003 BBaI13507 B1003 + rfp
BBaB1104 BBaB1004 BBaI13507 B1004 + rfp
BBa-B1105 BBaB1005 BBa-I13507 B1005 + rfp
BBa_31106 BBaB1006 BBaI13507 B1006 + rfp
BBa-B1107 BBa-B1007 BBaI13507 B1007 + rfp
BBaB1108 BBaB1008 BBa-I13507 B1008 + rfp
BBaB1109 BBaB1009 BBa_13507 B1009 + rfp
BBa-B1110 BBaB1010 BBa-I13507 B1010 + rfp
BBaB1201 BBaB1001 BBaI13504 BlOOl + gfp
BBaB1202 BBa-B1002 BBaI13504 B1002 + gfp
BBaB1203 BBaB1003 BBa-I13504 B1003 + gfp
BBaB1204 BBa-B1004 BBaI13504 B1004 + gfp
BBa-B1205 BBaB1005 BBaI13504 B1005 + gfp
BBaB1206 BBa-B1006 BBaI13504 B1006 + gfp
BBa-B1207 BBa_B1007 BBaI13504 B1007 + gfp
BBa-B1208 BBaB1008 BBa-I13504 B1008 + gfp
BBaB1209 BBa-B1009 BBaI13504 B1009 + gfp
BBa-B1210 BBa-B1010 BBa-I13504 BOlO + gfp
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Table 4.6: This table shows the second construction used to create the terminator
characterization devices. The intermediate part from the first construction is used as
the right part in this construction.
Part Name Left Part Right Part [Description
BBa-B3101 BBa-I13506 BBaB11O1 gfp + BlOOl + rfp
BBa-B3102 BBa-I13506 BBaB1102 gfp + B1002 + rfp
BBaB3103 BBaI13506 BBaB1103 gfp + B1003 + rfp
BBa-B3104 BBaI13506 BBaB1104 gfp + B1004 + rfp
BBaB3105 BBa-I13506 BBaiBl105 gfp + B1005 + rfp
BBaB3106 BBa-I13506 BBaB1106 gfp + B1006 + rfp
BBa-B3107 BBa-I13506 BBaB1107 gfp + B1007 + rfp
BBaB3108 BBa_113506 BBa-B1108 gfp + B1008 + rfp
BBaB3109 BBaI13506 BBa-B1109 gfp + B1009 + rfp
BBaB3110 BBa-I13506 BBa-B111O gfp + BlOlO + rfp
BBaB3201 BBaI13516 BBaB1201 rfp + BlOOl + gfp
BBa-B3202 BBaI13516 BBaB1202 rfp + B1002 + gfp
BBaB3203 BBa-I13516 BBa-B1203 rfp + B1003 + gfp
BBa-B3204 BBaI13516 BBaB1204 rfp + B1004 + gfp
BBa-B3205 BBaI13516 BBaB1205 rfp + B1005 + gfp
BBaiB3206 BBaI13516 BBaB1206 rfp + B1006 + gfp
BBaB3207 BBa-I13516 BBa-B1207 rfp + B1007 + gfp
BBaB3208 BBaI13516 BBaB1208 rfp + B1008 + gfp
BBaB3209 BBaI13516 BBaB1209 rfp + B1009 + gfp
BBa-B3210 BBa-I13516 BBa-B1210 rfp + BlOlO + gfp
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Figure 4-9: Triple antibiotic assembly is the method by which two BioBrick parts are
combined into a new part with a differnt antibiotic marker which can then be used
in futher constuctions. The image was taken from http://openwetware.mit.edu
4.2.1 Triple antibiotic assembly assembly
Triple antibiotic assembly is the method by which two BioBrick parts are combined
to form a new BioBrick. The process in shown in Figure 4-9. Each BioBrick has
a backbone which contains one of three different antibiotic markers: kanamycin,
tetracycline, or chloramphenicol. Having a choice of three markers ensures that a
new BioBrick part formed from two old parts will have a different resistance marker
than its components and allows for selection of that new part.
The first step in triple antibiotic assembly is selecting the correct backbone for
the assembly. The backbone is then cut with EcoRI and PstI. The two parts to be
combined are also cut: the first part with EcoRI and Spel, the second with XbaI and
PstI. When combined, the Spel and XbaI sites will form a mixed site which cannot
be cut with either enzyme. The digested backbone and inserts are then combined
and ligated with T4 ligase
In the ideal case, the backbone will combine with the two cut inserts to form the
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new BioBrick part. However, conditions in the ligation mixture are far from ideal.
Ideally, the only DNA present in the ligation mixture will be the backbone and the
inserts. Realistically, additional cut fragments such as backbones from the cut inserts
and sticky end fragments from the cut backbone are all present and will interfere with
the formation of the BioBrick part. A construct with multiple copies of one or both
inserts or constructs with no inserts may be possible. Constructs containing more
than one backbone ligated together are not viable, and do not have to be taken into
consideration. The resulting constructs are then transformed into Top10 cells.
4.2.2 Robotic assembly
Assemblies to make the constructs shown in 4.6 were performed on the epMotion5075
by Meagan Lizarazo. Assemblies that failed were then done by hand.
4.2.3 Verification
Colonies of constructs were picked onto an index plate, miniprepped, and sent out
for sequencing. The constructs from the robotics assemblies arrived in plasmid form,
were transformed into TOP10 cells, and then miniprepped as there was not enough
initial plasmid DNA for sequencing. The miniprepped DNA was then sent off for
sequencing.
The presence of full BioBrick prefix and suffix sequences in the sequencing results
demonstrated successful construction of a part. Common failure modes included the
inclusion of genomic DNA or the lack of an insert.
4.3 Transforming into an ideal strain
TOP10 cells are useful as competent cells for creating initial cell stocks but make a
poor experimental strain as it has the wild type arabinose operon. For the ParaBAD
promoter system to be fully functional, the characterization device must be in a strain
which has the arabinose transport genes knocked out. One such strain is CW2553
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developed by the Keating lab [11].
4.3.1 E. coli strain CW2553
The E. coli strain CW2553 (araE201, .araFGH::kan) has all arabinose transport genes
either deleted or mutated. The araE gene must be under the control of an arabinose
independent promoter to ensure homogenous induction of cells. In the study by
Khlebnikov et al. [11], putting araE under the control of the PCP 1 8 promoter resulted
in cells being homogeneously induced by arabinose in the media as well as producing
the highest concentrations of fluorescence. The pJAT18 plasmid contains araE under
the control of PCP18, and is included in the CW2553 strain obtained from the Endy
lab. The pJAT18 plasmid uses gentamicin as a resistance marker, so all transforms
will be grown on media containing gentamicin.
4.3.2 Making competent cells
A streaked plate containing CW2553 cells with pJAT18 was obtained from the Endy
lab. A colony was picked off the plate and grown overnight in 5ml of LB media. In
the morning, the culture was diluted into 500ml of LB, and grown until it reached an
OD6 00 of 0.4. The culture was split into two 225ml falcon tubes and incubated on ice
for 10 minutes.
The falcon tubes were centrifuged for 10 minutes at 3000rpm and 4 degrees C. The
supernatant was then removed and discarded, and the cell pellets were resuspended
in TSS buffer. TSS volume equal to 10% of the culture volume was used resuspend
the cells TSS buffer was prepared by adding 5g PEG 8000, 1.5 ml 1M MgC 2 , and
2.5 ml of DMSO to LB media to a final volume of 50ml. The TSS buffer was then
filter sterilized and chilled to 4 degrees C. The resulting cell solution was aliquoted
into lml eppendorf tubes and stored at -80 degrees C.
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4.3.3 Transformation of characterization devices into CW2553
Both the characterization devices and controls were transformed into CW2553/pJAT18.
One ul of miniprepped DNA from a characterization device or control was added to
50ul of competent cells, and incubated on ice for 30 minutes. The cells were then heat
shocked at 42 degrees C for 50 seconds, and put back on ice for two minutes. 250 ul
of SOC media was added to each tube of cells, and the cells were incubated at 37 de-
grees C for two hours to recover antibiotic resistance. After incubation, the cells were
spread on plates containing both gentamicin and ampicillin and grown overnight. A
colony was picked off each plate and made into a glycerol for future use.
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Chapter 5
Using Characterization Devices to
Measure Termination Efficiency
The terminators were characterized by measuring the inputs and outputs of the char-
acterization devices using a protocol developed by Jason Kelly of the Endy lab [12].
The characterization devices were grown in supplemented M9 media overnight, and
then induced with arabinose. The following day, aliquots of the cultures were taken
to the MIT Flow Lab, and the induced fluorescence was measured.
5.1 Materials
Setting up experimental cultures required preparation of a rich media such as M9,
and a solution of 1% arabinose for induction. Cultures containing the characterization
devices were streaked on plates and grown overnight to check for viability. One colony
of each strain was used to start a new experimental culture. Five controls were used
to gauge the accuracy and validity of the experimental cultures.
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5.1.1 Media
M9 supplemented Media
Initially, 2L of Ix supplemented M9 media were made. The requirements from making
a litre of supplemented M9 is listed below. This recipe was found on openwetware.
* 200 ml of M9 minimal salts at 5X concentration
* 34 ml of thiamine at 10mg/ml
* 10 ml of 40% glycerol
* 20 ml of 10% Casamino acids
* 2 ml of 1M MgSO4
* 100 ul of IM CaCl2
* 733.9 ml of sterile deionized H2 0
The following instructions were followed to make 2L of supplemented M9 media
To dissolve the M9 minimal salts, 22.6 grams of Bacto M9 minimal salts, in a con-
centration of 5X from Difco, was dissolved in 400 ml of H20. 780 mg of thiamine was
dissolved in 78 ml of H20, and filter sterilized. An equal amount of H2 0 was added
to 20ml of 80% glycerol to dilute it to 40% glycerol. 20 g of Bacto Casamino acids
from Difco was dissolved in 200 mL of H2 0 to create a 10% solution of casamino
acids. To make a 1M MgSO4 solution, 24.65g of MgSO4 * 7H20 was dissolved in
100ml of H2 0. Likewise, 14.7g of CaCl2 * 2H 20 was dissolved in 100 ml of H2 0
to create a IM solution. All except for the thiamine solution were autoclaved at
121 degrees C for 15 minutes to sterilize. The thiamine solution was filter sterilized.
The ingredients were added to 733.9 ml of sterile deionized H2 0 following the recipe
listed above. The media was then split into 1 IL bottle and 2 500 ml bottles, and
appropriate antibiotics added to each bottle. Both gentamicin and ampicillin were
added to 1.5 L of media, and the remaining 500 ml had only gentamicin added to it.
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Arabinose
An initial stock solution of 1% arabinose by weight was made by adding 1 g of L-
arabinose to 100ml of H20 and filter sterilized. The stock solution was then further
diluted to create a 0.1% arabinose solution used to induce the characterization devices
in the experimental cultures.
5.1.2 Characterization Devices
Cultures containing the characterization devices shown in 4.4 were streaked on plates
to check for viability. A single colony from each plate was then used to start an
experimental culture.
5.1.3 Controls
The experimental controls used to validate the experimental cultures were previ-
ously shown in 4.3. Controls 113514 and 113515 were used to calibrate the inputs
and outputs; while controls 113521 and 113522 provided the maximum expression
levels of RFP and GFP. The negative control for this experiment was a culture of
CW2553/pJAT18 containing no BioBrick plasmids. Care had to be taken not to
accidently grow the negative control in media unsuitable for it.
5.2 Protocols
Each characterization device and control were first streaked out on plates. One colony
from each plate was grown in 5ml M9 with the appropriate antibiotic was grown for 24
hours at 37 degrees C. The OD600 of each culture was then measured and recorded.
Each culture was diluted to an OD600 of approximately 0.07, which contains around
104 CFU.
The diluted cultures were then grown from 2 hours at 37 degrees C, and fluorescent
protein expression was induced with arabinose. Studies have shown that the best
range for arabinose induction is between 0.0001% and 0.01% (Khlebinokov). All
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samples were induced with 5ul of 0.1% arabinose in 5ml of culture, creating a final
arabinose concentration of 0.001%.
The induced samples were then grown overnight for 12-14 hours to maximize
fluorescent protein expression. The following morning, lml aliquots of each cultures
were placed in falcon 3026 polypropylene tubes on ice to stop further growth. The
aliquots were taken the MIT Flow lab, and GFP and RFP expression were measured.
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Chapter 6
Results
6.1 Controls
Five controls were measured in this experiment. CW2553/pJAT18 was used as the
negative control to determine the ranges of background fluorescence. 113521 and
113522 constitutively expressed RFP and GFP respectively. 113514 and 113515 mea-
sured the GFP and RFP expression of the two versions of the characterization plas-
mids, but lacked the internal terminator under test. The mean GFP and RFP fluo-
rescence and the standard deviations of these controls are shown in Table 6.1.
6.1.1 Constitutive expression of RFP and GFP
113521 and 113522 provide a baseline measurement of reasonable ranges of RFP and
GFP fluorescence. Figure 6-1 shows the measured fluorescence of these controls. The
sample 113521 has a mixture of fluorescent and nonfluorescent cells. For purposes of
calculating the mean and standard deviation of the cell population in 113521, only
cells expressing sufficient fluorescence, defined as being above 4std of the negative
control, were included.
As expected, 113521 has negligible GFP expression and 113522 has negligible RFP
expression. The mean RFP of 113521 was 83.92, compared to the negative control of
2.17. The mean GFP of 113522 was 15.12, compared to a negative control of 2.86. It
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Table 6.1: This table shows the average GFP and RFP expression of the negative
control, 113514, 113515, 113521 and 113522. 113521 and 113522 constitutively express
RFP and GFP respectively. 113514 and 113515 are used to calibrate input and out-
put measurements of the characterization devices. In cases of 113514 and 113521,
which have two distinct populations of cells, the
fluorescence are discounted from the mean.
cells which do not express sufficient
Sample Description Mean GFP Std GFP Mean RFP Std RFP
CW2553 no fluorescence 2.86 1.32 2.18 0.81
113521 constitutive RFP only 3.81 1.96 83.92 77.25
113522 constitutive GFP only 15.12 13.07 2.17 0.60
113514 inducible GFP/RFP 20.73 23.05 17.2 14.65
113515 inducible RFP/GFP 210.30 102.48 2.22 0.62
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Figure 6-1: This figure shows the measured GFP and RFP of controls 113521 and
113522 as compared to the negative control CW2553/pJAT18. Controls 113521 and
113522 respectively express RFP and GFP constitutively. As expected, 113521 has
negligible GFP expression and 113522 has negligible RFP expression. The sample
113521 contained a population of cells that produced neither GFP nor RFP, and
those cells were ignored when calculating the mean RFP expression. The mean RFP
of 113521 was 83.92, compared to the negative control of 2.17. The mean GFP
of 113522 was 15.12, compared to a negative control of 2.86. It is not know why
constitutive GFP expression was much lower than constitutive RFP expression.
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Figure 6-2: This figure shows the measured GFP and RFP of controls 113514 and
113515 as compared to the negative control CW2553/pJAT18. Ideally, 113514 and
113515 should have the same levels of GFP and RFP. The majority of cells with the
plasmid 113514 produced no significant amounts of GFP or RFP. Of the cells produc-
ing significant fluorescence, the mean GFP expression was 20.73, and the mean RFP
expression was 17.2. As the majority of cells produced neither GFP nor RFP, 113514
cannot be used to accurately calibrate the ratio of input to output of a terminator
under test in version 1 of the characterization plasmid. Due the possible presence of
an RNAse cut site in the RFP coding region, the control 113515 produced negligible
RFP. The mean GFP expression for 113515 was 210.3.
is not know why constitutive GFP expression was much lower than constitutive RFP
expression.
6.1.2 Expression of RFP and GFP from empty characteriza-
tion plasmids
113514 and 113515 are the empty versions of the characterization plasmids, lacking
the terminator under test. 113514 has GFP followed by RFP under the control of
the arabinose promoter ParaBAD. 113515 is similar, having RFP followed by GFP
under the control of the same promoter. Figure 6-2 shows the measured fluorescence
of these controls.
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3
113514
The cell population of 113514 contains a mixture of nonfluorescent cells, cells only
expressing RFP, and cells expressing both RFP and GFP. The majority of the cells
express no significant levels of fluorescence. Of the cells producing significant fluores-
cence, the mean GFP expression was 20.73, and the mean RFP expression was 17.2.
As such, the measurements taken from 113514 cannot be accurately used to calibrate
the input (in terms of GFP) to the output (in terms of RFP).
113515
The cell population of 113515 does not express significant levels of RFP, but expresses
high levels of GFP, with a mean GFP expression of 210.30. This may be due to the
possible existence of an internal RNAse site in the RFP coding region, which causes
fast degradation of RFP mRNA. In effect, the characterization plasmid would only
have GFP to measure output of the terminator, instead of RFP to measure input and
GFP to measure output.
6.2 Terminators
Ten terminators were characterized using two versions of the characterization plasmid.
Version 1, shown previously in Figure 4-1, contained GFP, followed by the terminator
under test and RFP under the control of the arabinose promoter ParaBAD. Version
2 switched the locations of the RFP and GFP coding regions, but was otherwise the
same, and was shown previously in Figure 4-2. Under ideal circumstances, if a strong
terminator was placed into characterization plasmid 1, the only output should be
GFP. Likewise, if a strong terminator was present in characterization plasmid 2, only
RFP should be visible as the output.
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Figure 6-3: This figure shows the GFP vs RFP expression of each cell in the sample
of B3101 compared to the negative control CW2553 and the empty characterization
plasmid 113514. The mean GFP expression for B3101 is 5.71 compared to 2.86 for
the negative control and 20.73 for 113514. The mean RFP for B3101, 2.17, is the
same as the negative control, and significantly less than the mean RFP of 113514,
17.2. B3101 produces both low levels of GFP and RFP, contrary to the initial belief
that it would produce levels of GFP close to that of 113514, but low RFP. The ter-
minator tested, B1001, is unlikely to be a strong terminator. The actual termination
efficiency cannot be determined as the control 113514 has a majority of cells that
produce no significant fluorescence, and cannot be used to accurately calibrate input
measurements to output measurements.
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Figure 6-4: This figure shows the GFP vs RFP expression of each cell in the sample
of B3102 compared to the negative control CW2553 and the empty characterization
plasmid 113514. The mean GFP expression for B3101 is 22.42 compared to 2.86 for
the negative control and 20.73 for 113514. The mean RFP for B3102, 2.23, is the
same as the negative control, and significantly less than the mean RFP of 113514,
17.2. B3102 produces a similar amount of GFP compared to the control 113514,
but negligible RFP, and is likely to be a strong terminator. The actual termination
efficiency cannot be determined as the control 113514 has a majority of cells that
produce no significant fluorescence, and cannot be used to accurately calibrate input
measurements to output measurements.
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Figure 6-5: This figure shows the GFP vs RFP expression of each cell in the sample
of B3103 compared to the negative control CW2553 and the empty characterization
plasmid I13514. The mean GEP expression for B3103 is 11.18 compared to 2.86 for the
negative control and 20.73 for I13514. The mean REP for B3103, 2.17, is the same as
the negative control, and significantly less than the mean REP of I13514, 17.2. B3103
produces only 54% of GFP of the control 113514, but negligible REP, and is unlikely
to be strong terminator. The actual termination efficiency cannot be determined as
the control 113514 has a majority of cells that produce no significant fluorescence, and
cannot be used to accurately calibrate input measurements to output measurements.
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Figure 6-6: This figure shows the GFP vs RFP expression of each cell in the sample
of B3104 compared to the negative control CW2553 and the empty characterization
plasmid 113514. The mean GFP expression for B3101 is 22.47 compared to 2.86 for
the negative control and 20.73 for 113514. The mean RFP for B3104, 2.16, is the
same as the negative control, and significantly less than the mean RFP of 113514,
17.2. B3104 produces a similar amount of GFP compared to the control 113514,
but negligible RFP, and is likely to be a strong terminator. The actual termination
efficiency cannot be determined as the control 113514 has a majority of cells that
produce no significant fluorescence, and cannot be used to accurately calibrate input
measurements to output measurements.
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Figure 6-7: This figure shows the GFP vs RFP expression of each cell in the sample
of B3105 compared to the negative control CW2553 and the empty characterization
plasmid 113514. The mean GFP expression for B3105 is 3.69 compared to 2.86 for the
negative control and 20.73 for 113514. The mean RFP for B3101, 2.19, is the same as
the negative control, and significantly less than the mean RFP of 113514, 17.2. B3105
produces both low levels of GFP and RFP, contrary to the inital belief that it would
produce levels of GFP close to that of 113514, but low RFP. The terminator tested,
B1005, is unlikely to be a strong terminator as it affects input as well as output.
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Figure 6-8: This figure shows the GFP vs RFP expression of each cell in the sample
of B3106 compared to the negative control CW2553 and the empty characterization
plasmid 113514. The mean GFP expression for B3106 is 24.86 compared to 2.86 for
the negative control and 20.73 for 113514. The mean RFP for B3106, 2.16, is the
same as the negative control, and significantly less than the mean RFP of 113514,
17.2. B3106 produces a similar amount of GFP compared to the control 113514,
but negligible RFP, and is likely to be a strong terminator. The actual termination
efficiency cannot be determined as the control 113514 has a majority of cells that
produce no significant fluorescence, and cannot be used to accurately calibrate input
measurements to output measurements.
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Figure 6-9: This figure shows the GFP vs RFP expression of each cell in the sample
of B3107 compared to the negative control CW2553 and the empty characterization
plasmid 113514. The mean GFP expression for B3107 is 14.34 compared to 2.86 for the
negative control and 20.73 for 113514. The mean RFP for B3107, 2.18, is the same as
the negative control, and significantly less than the mean RFP of 113514, 17.2. B3107
produces only 69% of GFP of the control 113514, but negligible RFP, and is unlikely
to be strong terminator. The actual termination efficiency cannot be determined as
the control 113514 has a majority of cells that produce no significant fluorescence, and
cannot be used to accurately calibrate input measurements to output measurements.
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Figure 6-10: This figure shows the GFP vs RFP expression of each cell in the sample
of B3108 compared to the negative control CW2553 and the empty characterization
plasmid 113514. The mean GFP expression for B3108 is 8.59 compared to 2.86 for the
negative control and 20.73 for 113514. The mean RFP for B3108, 2.18, is the same as
the negative control, and significantly less than the mean RFP of 113514, 17.2. B3108
produces only 41% of GFP of the control 113514, but negligible RFP, and is unlikely
to be strong terminator. The actual termination efficiency cannot be determined as
the control 113514 has a majority of cells that produce no significant fluorescence, and
cannot be used to accurately calibrate input measurements to output measurements.
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Figure 6-11: This figure shows the GFP vs RFP expression of each cell in the sample
of B3109 compared to the negative control CW2553 and the empty characterization
plasmid 113514. The mean GFP expression for B3101 is 3.57 compared to 2.86 for the
negative control and 20.73 for 113514. The mean RFP for B3109, 2.18, is the same as
the negative control, and significantly less than the mean REP of I13514, 17.2. B3109
produces both low levels of GFP and REP, contrary to the initial belief that it would
produce levels of GEP close to that of 113514, but low REP. The terminator tested,
B1009, is unlikely to be a strong terminator as it affects input as well as output.
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Figure 6-12: This figure shows the GFP vs RFP expression of each cell in the sample
of B3110 compared to the negative control CW2553 and the empty characterization
plasmid 113514. The mean GFP expression for B3110 is 25.48 compared to 2.86
for the negative control and 20.73 for 113514. The mean RFP for B3110, 2.60, is
the close the negative control, and significantly less than the mean RFP of 113514,
17.2. B3110 produces a similar amount of GFP compared to the control 113514,
but negligible RFP, and is likely to be a strong terminator. The actual termination
efficiency cannot be determined as the control 113514 has a majority of cells that
produce no significant fluorescence, and cannot be used to accurately calibrate input
measurements to output measurements.
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Table 6.2: This table shows the mean GFP and RFP expression of characterization
plasmids B3101 through B3110. The mean GFP and RFP expression of the negative
control CW2553/pJAT18 and 113514 are shown for comparison.
Sample Mean GFP std GFP Mean RFP std RFP
CW2553/pJAT18 2.86 1.32 2.18 0.81
113514 20.73 23.05 17.2 14.65
B3101 5.71 9.65 2.17 0.62
B3102 22.42 19.39 2.23 0.78
B3103 11.18 8.92 2.17 0.61
B3104 22.47 26.24 2.16 0.59
B3105 3.69 2.52 2.19 0.0.62
B3106 24.86 23.88 2.16 0.60
B3107 14.34 11.67 2.18 0.60
B3108 8.59 5.71 2.17 0.60
B3109 3.57 1.73 2.18 0.62
B3110 1 25.48 33.25 2.60 1.92
6.2.1 Results of characterization plasmid 1
Table 6.2 shows the mean GFP and RFP expression of characterization plasmids
B3101 through B3110 as compared to both the negative control, CW2553/pJAT18
and the empty characterization plasmid 113514. The mean RFP expression of all
the characterization plasmids was negligible when compared to the negative control.
Mean GFP expression ranged from negligible compared to the negative control to
close to the maximum indicated by 113514. The range in mean GFP of the different
characterization plasmids was unexpected as the presence of the terminator under
test should only affect the coding region downstream from it. The exact fluorescence
measurements of each characterization plasmid are shown in Figures 6-3 through 6-12.
Of the ten terminators tested with this version of the characterization device, four
behaved in such a way that indicated high termination efficiency. Devices containing
terminators B1002, B1004, B1006, and B1010 all expressed minimal levels of RFP
and high levels of GFP. Devices containing terminators B1001, B1005, and B1009
expressed minimal levels of both GFP and RFP, and as such the termination efficiency
of those terminators cannot be accurately judged with these results.
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Table 6.3: This table shows the mean GFP and mean RFP expression of character-
ization plasmids B3201 through B3210. The mean GFP and RFP expression of the
negative control CW2553/pJAT18 and 113515 are shown also for comparison.
Sample Mean GFP std GFP Mean RFP std RFP
CW2553/pJAT18 2.86 1.32 2.18 0.81
113515 210.30 102.48 2.22 0.62
B3201 37.95 40.89 2.82 1.46
B3202 3.14 1.61 2.17 0.60
B3203 33.87 41.70 2.34 0.81
B3204 13.28 14.71 2.59 1.17
B3205 29.70 32.85 3.16 2.02
B3206 4.20 4.98 2.18 0.67
B3207 35.85 29.08 3.02 1.55
B3208 9.90 8.04 2.19 0.62
B3209 12.50 9.56 2.20 0.62
B3210 9.01 6.17 2.18 0.60
6.2.2 Results of characterization plasmid 2
Table 6.3 shows the mean GFP and RFP expression of characterization plasmids
B3201 through B3210. All these characterization plasmids had the same flaw as the
control plasmid 113515. The possible presence of an RNAse site in the RFP coding
region made it such that there was limited RFP expression in all the characterization
plasmids, and input to the terminators could not be accurately measured. Figures
6-13 through 6-22 show the exact fluorescence of these characterization plasmids.
For these characterization devices, it is necessary to ignore the RFP measurements,
as these devices can only accurately measure the GFP output. A strong terminator
characterized by one of these devices will show low levels of GFP output, while a weak
terminator will show high levels. The average GFP measured on the empty plasmid
113515 was 210.30. Of the terminators tested with these characterization plasmids,
B1002 and B1006 cause the greatest decrease of mean GFP expression to 3.14 and
4.2 respectively.
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Figure 6-13: This figure shows the GFP vs RFP expression of each cell in the sample
of B3201 compared to the negative control CW2553 and the empty characterization
plasmid 113515. Due to the presence of RNAse cut site in the RFP coding region
upstream of the terminator, only the output of the terminator can be measured. The
presence of terminator B1001 reduces the mean GFP output from 210.30 as measured
by the control 113515 to 37.95, decreasing the output by 81%
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Figure 6-14: This figure shows the GFP vs RFP expression of each cell in the sample
of B3202 compared to the negative control CW2553 and the empty characterization
plasmid 113515. Due to the presence of RNAse cut site in the RFP coding region
upstream of the terminator, only the output of the terminator can be measured. The
presence of terminator B1002 reduces the mean GFP output from 210.30 as measured
by the control 113515 to 3.14, decreasing the output by 99%
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Figure 6-15: This figure shows the GFP vs RFP expression of each cell in the sample
of B3203 compared to the negative control CW2553 and the empty characterization
plasmid 113515. Due to the presence of RNAse cut site in the RFP coding region
upstream of the terminator, only the output of the terminator can be measured. The
presence of terminator B1003 reduces the mean GFP output from 210.30 as measured
by the control 113515 to 33.87, decreasing the output by 83%
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Figure 6-16: This figure shows the GFP vs RFP expression of each cell in the sample
of B3204 compared to the negative control CW2553 and the empty characterization
plasmid 113515. Due to the presence of RNAse cut site in the RFP coding region
upstream of the terminator, only the output of the terminator can be measured. The
presence of terminator B1004 reduces the mean GFP output from 210.30 as measured
by the control 113515 to 13.28, decreasing the output by 94%
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Figure 6-17: This figure shows the GFP vs RFP expression of each cell in the sample
of B3205 compared to the negative control CW2553 and the empty characterization
plasmid 113515. Due to the presence of RNAse cut site in the RFP coding region
upstream of the terminator, only the output of the terminator can be measured. The
presence of terminator B1005 reduces the mean GFP output from 210.30 as measured
by the control 113515 to 29.70, decreasing the output by 86%
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Figure 6-18: This figure shows the GFP vs RFP expression of each cell in the sample
of B3206 compared to the negative control CW2553 and the empty characterization
plasmid 113515. Due to the presence of RNAse cut site in the RFP coding region
upstream of the terminator, only the output of the terminator can be measured. The
presence of terminator B 1006 reduces the mean GFP output from 210.30 as measured
by the control I13515 to 4.20, decreasing the output by 98%
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Figure 6-19: This figure shows the GFP vs RFP expression of each cell in the sample
of B3207 compared to the negative control CW2553 and the empty characterization
plasmid 113515. Due to the presence of RNAse cut site in the RFP coding region
upstream of the terminator, only the output of the terminator can be measured. The
presence of terminator B1007 reduces the mean GFP output from 210.30 as measured
by the control 113515 to 35.85, decreasing the output by 83%
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Figure 6-20: This figure shows the GFP vs RFP expression of each cell in the sample
of B3208 compared to the negative control CW2553 and the empty characterization
plasmid 113515. Due to the presence of RNAse cut site in the RFP coding region
upstream of the terminator, only the output of the terminator can be measured. The
presence of terminator B1008 reduces the mean GFP output from 210.30 as measured
by the control 113515 to 9.90, decreasing the output by 95%
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Figure 6-21: This figure shows the GFP vs RFP expression of each cell in the sample
of B3209 compared to the negative control CW2553 and the empty characterization
plasmid 113515. Due to the presence of RNAse cut site in the RFP coding region
upstream of the terminator, only the output of the terminator can be measured. The
presence of terminator B 1009 reduces the mean GFP output from 210.30 as measured
by the control I13515 to 12.50, decreasing the output by 94%
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Figure 6-22: This figure shows the GFP vs RFP expression of each cell in the sample
of B3210 compared to the negative control CW2553 and the empty characterization
plasmid 113515. Due to the presence of RNAse cut site in the RFP coding region
upstream of the terminator, only the output of the terminator can be measured. The
presence of terminator BlOlO reduces the mean GFP output from 210.30 as measured
by the control 113515 to 9.01, decreasing the output by 96%
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Table 6.4: This table shows the termination efficiencies of the new BioBrick termi-
nators B1001 through B1010. The strongest terminators are B1002 and B1006. The
weakest terminator is B1001.
Terminator 11 TE
B1001 _T0.81
B1002 0.99
B1003 0.83
B1004 0.93
B1005 0.86
B1006 0.98
B1007 0.83
B1008 0.95
B1009 0.94
B1010 0.95
6.3 Termination Efficiency
Only the results from the second set of characterization devices were used to calculate
termination efficiency. The control for the first set, 113514, did not have enough cells
with significant GFP or RFP expression to accurately measure input and output of the
terminator under test. Calculations of termination efficiency can be performed with
only the output of the terminators, measured by the second set of characterization
devices. Termination efficiency would be measured by the ratio of the mean GFP
of a characterization device to the mean GFP of control 113515. The mean TE was
calculated by average the TE of each cell in the sample population. Termination
efficiency was calculated by the following formula.
Table 6.4 shows the average termination efficiency of the artificial BioBrick termi-
nators B1001 through B1010 while Figures 6-23 through 6-32 show the histograms of
the TE of the terminators as measured by the second set of characterization devices.
Terminators B1002 and B1006 are the strongest terminators with mean % TE of
.99 and .98 respectively. Other strong terminator with a % TE above .9 are B1004,
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Figure 6-23: The figure shows a histogram of the termination efficiency of the termina-
tor B1001, calculated using the data from B3201. The average termination efficiency
is 0.81.
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Figure 6-24: The figure shows a histogram of the termination efficiency of the termina-
tor B1002, calculated using the data from B3202. The average termination efficiency
is 0.99.
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Figure 6-25: The figure shows a histogram of the termination efficiency of the termina-
tor B1003, calculated using the data from B3203. The average termination efficiency
is 0.83.
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Figure 6-26: The figure shows a histogram of the termination efficiency of the termina-
tor B1004, calculated using the data from B3204. The average termination efficiency
is 0.94.
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Figure 6-27: The figure shows a histogram of the termination efficiency of the termina-
tor B1005, calculated using the data from B3205. The average termination efficiency
is 0.86.
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Figure 6-28: The figure shows a histogram of the termination efficiency of the termina-
tor B1006, calculated using the data from B3206. The average termination efficiency
is 0.98.
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Figure 6-29: The figure shows a histogram of the termination efficiency of the termina-
tor B1007, calculated using the data from B3207. The average termination efficiency
is 0.83.
TE of B1008
12000-
0
E
8000-
6000-
4000-
2000-
0.2 0 0.2 0.4 0.6
percent TE
0.8 1 1.2
Figure 6-30: The figure shows a histogram of the
nator B10, calculated using the data from B3208.
is 0.95.
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The average termination efficiency
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Figure 6-31: The figure shows a histogram of the termination efficiency of the termina-
tor B1009, calculated using the data from B3209. The average termination efficiency
is 0.94.
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Figure 6-32: The figure shows a histogram of the termination efficiency of the termina-
tor B1010, calculated using the data from B3210. The average termination efficiency
is 0.96.
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B1008, B1009, and B1010. The remaining four terminators, B1001, B1003, B1005
and B1007 are all weaker, with % TE under .86. As these termination efficiencies
were only calculated with the data from the second set of characterization plasmids,
no final conclusions can be made until the behavior of the terminators is verified with
the first set of characterization plasmids.
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Chapter 7
Discussion
Differences in data from the two different characterization devices need to be re-
solved. Several terminators, when tested with characterization plasmid 1, reduced
the expression of the upstream GFP as well as the downstream RFP but testing
with characterization plasmid 2 shows that they have high termination efficiency. In
addition, the actual termination efficiencies were very different from the predicted
values.
7.1 Effects of mRNA stability
The presence of an RNAse site in the RFP coding region would destabilize the mRNA
for both proteins and result in minimal RFP expression in all samples. A strong
hairpin of a terminator would help stabilize the mRNA after it has been cut, and slow
the rate of degradation. When using the version of the characterization plasmid with
GFP upstream of the terminator and RFP downstream, the terminator under test
would have the job of stabilizing the remaining mRNA. A strong terminator would be
able to slow the degradation of the remaining mRNA, so the resulting system would
have high levels of GFP expression. A weak terminator would be unable to protect
the remaining mRNA, causing the GFP coding region to be degraded as well. The
resulting systems would then produce neither GFP nor RFP.
Of the terminators tested, B1002, B1004, B1006, and B1010 proved to be strong
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Table 7.1: This table shows the termination efficiencies of the new BioBrick termi-
nators BlOOl through B1010 as well as the mRNA stabilization ability. mRNA sta-
bilization is based on much GFP was produced a terminator was tested with version
1 of the characterization plasmid as compared to control 113514. Strong terminators
should also be able to stabilize mRNA better than weak terminators. B1008 and
B1009 have high % TE, but are unable to stabilize mRNA. As the data from the two
different characterization plasmids conflict for these two terminators, no conclusions
can be made about them. The best terminators are B1002, B1004, B1006 and B1010.
Terminator 11 TE GFP produced
BlOOl 0.81 0.28
B1002 0.99 1.08
B1003 0.83 0.54
B1004 0.93 1.08
B1005 0.86 0.18
B1006 0.98 1.20
B1007 0.83 0.69
B1008 0.95 0.41
B1009 0.94 0.18
B1010 0.95 1.23
enough to prevent degradation of the GFP coding region. Terminators B1001, B1005,
and B1009 proved to be poor at mRNA stabilization as shown by the fact that they
have the lowest levels of GFP expression compared to the control 113514. The remain-
ing terminators B1003, B1007 and B1008 provided a moderate amount of protection
and allowed approximately 50% GFP expression as compared to the control.
Table 7.1 shows a summary of the BioBrick terminators and their termination ef-
ficiencies, as well as their ability to stabilize mRNA. With the exception of B1008 and
B1009, the stong terminators were able to prevent degradation of the GFP mRNA in
the first characterization plasmid. Conclusions of the termination efficiency of B1008
and B1009 cannot be made as their behavior in the two characterization plasmids
contradict each other. The four best terminators are B1002, B1004, B1006, and
B1010.
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Table 7.2: This table shows sequences, predicted % TE, measured % TE, and the
error in the prediction. The strongest terminators are B1002, B1006, B1010, and
B1004. The formula used to predict termination efficiency was most accurate when
the terminator had approximately 6 thymine residues in the tail. The most accurately
predicted terminators were B1002, B1003, B1006 and B1007..
Terminator Predicted TE Measured TE error
BBaB1001 0.95 0.81 0.17
BBaB1002 0.90 0.99 0.09
BBa-B1003 0.80 0.83 0.04
BBaB1004 0.55 0.93 0.40
BBaB1005 0.25 0.86 0.70
BBaB1006 0.95 0.98 0.03
BBaB1007 0.80 0.83 0.04
BBaB1008 0.70 N/A N/A
BBaB1009 0.40 N/A N/A
BBaB11010 0.10 0.95 0.89
7.2 Accuracy of predicted termination efficiencies
The most accurate predictions of termination efficiency occurred when the terminator
in question had a poly(T) tail of approximately 6nt. The formula was least accurate
when predicting termination efficiencies of terminators with tails less than 5nt long.
predicted termination efficiencies of the new BioBrick terminators are shown in Table
7.2.
The most surprising result was that B1010 proved to be one of the most effective
terminators while B1001 had the lowest termination efficiency. Since B1010 only had
a 3nt T tail and a long stem loop structure, its predicted termination efficiency was
only around 0.1 but its actual termination efficiency was measured to be 0.95. The
terminator B1004 was another terminator that proved to be much more successful
than predicted, with a predicted % TE of .55 but an actual % TE of 0.93. B1005,
while not as effective as B1010 or B1004, had a measured % TE of .86, but was
predicted to have a % TE of .25. B1001, contrary to initial expectations, was a poor
terminator despite a poly(T) tail of 9nt and a high t score. It is not known at this
time why these terminators behaved in this manner.
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Of the remaining terminators, B1002, B1003, B1006 and B1007 all behaved as
expected, with the predicted termination efficiency coming within 10% of the mea-
sured termination efficiency. Terminators B1008 and B1009 could not be accurately
characterized, and as such, no comparisons could be made between the measured ter-
mination efficiency and the predicted. This leads to the conclusion that the formula
used to predict termination efficiency is most accurate when applied to terminators
with moderate poly(T) tails of approximately 6nt in length.
7.3 Future works
Several things can be done to improve the terminators in the future. The first thing
to do would be to verify and retest the control plasmid 113514 to determine why
only a minority of the cells carrying that plasmid produce sufficient GFP and RFP.
This may be due to mRNA instability, but further tests should be performed, and,
if necessary, a new control designed. The control plasmid 113515 should also be
updated to prevent mRNA stability by removing mRNA3 cut sites from the RFP
coding region or use hairpins to stabilize the remaining mRNA if the cut site cannot
be moved. The constitutive controls of 113521 and 113522 should also be reviewed to
see if the fluorescence of these controls could be increased.
In future experiments, calibration beads will be run on the flow cytometer, so
data from different days of measurements can be compared. Three sets of measure-
ments were taken during when the terminators were characterized, but only one set
could be analyzed. While the results were overall consistent across multiple days of
measurements, minor differences in the setup of the machine made combining those
measurements ill advised. Running calibration beads at the start of each session
of flow cytometry will provide a baseline to compare the performance of the flow
cytometer across different days.
Further studies into designing new terminators will include using the device char-
acterization plasmid designed by Endy Lab to characterize any new terminators.
Using the Endy Lab plasmid will result in reducing the number of constructions nec-
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essary to prepare a BioBrick part for characterization. New terminators will have
more varied stem loops in an attempt to vary termination efficiency, and will have
thymine tails of approximately 6nt to maximize the effectiveness of the formula used
to predict termination efficiency.
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Chapter 8
Conclusion
Ten new terminators were designed based on previous research of terminator structure
and termination efficiency. The terminators were built by PCR extension, ligated into
a BioBrick plasmid backbone, and transformed into TOP10 cells. Characterization
devices were built to test the terminators. Input and output of the terminator were
measured by expression of RFP and GFP. Characterization devices were then placed
into the E. coli strain CW2553/pJAT18, which hijacks the arabinose transport system
to provide controlled input to the terminator.
Of the ten terminators designed and tested, B1002, B1004, B1006 and B1010
proved to be strong terminators with termination efficiencies above 90%. Terminators
B1001, B1003, B1005 and B1007 were weaker, all with termination between 80% and
86%. Due to conflicting data, no conclusions could be made about terminators B1008
or B1009.
The algorithm used to predict termination efficiency based on terminator sequence
was most accurate for terminators with poly(T) tails of around 6nt. The error be-
tween the predicted and actual termination efficiencies were under 10% for termina-
tors B1002, B1003, B1006, and B1007. Predictions for termination efficiencies for
terminators with the shortest tails, B1005 and B1010 were least accurate, with errors
above 80%.
All terminations characterization in this project were added to the Registry of
Standardized Parts at http://parts.mit.edu. Future studies will include the design of
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better controls and measurement methods as well as attempting to expand the range
of termination efficiencies for designed terminators
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